₹15.98
+₹0.30 (+1.91%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹69 Cr
P/E
-3.82
ROE
-22.95%
ROCE
-11.16%
About Bharat Immunological & Biological Corporation Ltd
Bharat Immunological & Biolog.Corp. is engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarehha management Kit and BIB Sweet Tablets.(Source : 202303 Annual Report Page No:05)
Founded
1989
CEO
Y K Gupta
Employees
0
HQ
Bulandshahr, Uttar Pradesh
About Bharat Immunological & Biological Corporation Ltd
Bharat Immunological & Biolog.Corp. is engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarehha management Kit and BIB Sweet Tablets.(Source : 202303 Annual Report Page No:05)
Founded:1989
CEO:Y K Gupta
Employees:0
HQ:Bulandshahr, Uttar Pradesh
Finished Products
1Sale of Products
₹123.00CrRaw Materials
1Raw Material Consumed
₹92.22Cr2Packing materials
₹8.41CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹23
52W Low
₹14
Volume20.67K
Avg VolumeN/A
Beta0.89
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-3.82x
Valuation
P/B Ratio
N/A
Valuation
EPS
₹-4.18
Valuation
Dividend Yield
0.00%
Valuation
ROE
-22.95%
Profitability
ROCE
-11.16%
Profitability
Revenue by Segment
Contribution & growth by business line
Oral Polio Vaccine
-43.1%100.0%
₹44.609 Cr
BIBSANIT
-99.4%0.0%
₹0 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.94x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-19.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.